Source: Eur Respir J 2006; 27: 997-1002



Rating:

Share or cite this content

Citations should be made in the following way:
El Solh A. A., Saliba R., Bosinski T., Grant B. J. B., Berbary E., Miller N.. Allopurinol improves endothelial function in sleep apnoea: a randomised controlled study. Eur Respir J 2006; 27: 997-1002

Member's Comments

No comment yet.

Related content which might interest you: Sleep apnoea, hypertension and vascular disease: where are we now? Source: Eur Respir Rev 2007; 16: 169-182 Year: 2007 Obstructive sleep apnoea: who should be treated? Source: Annual Congress 2005 - PG12 - Sleep-related problems: treatment of obstructive sleep apnoea - current concepts and perspectives Year: 2005 The effect of obstructive sleep apnoea on the retinal vascular reactivity: a randomised trial Source: Virtual Congress 2021 – Different treatment modalities and impact of comorbidities on sleep disordered breathing Year: 2021 Response to statin therapy in obstructive sleep apnea (OSA): A randomized controlled trial Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013 Prevalence of residual excessive sleepiness in CPAP-treated sleep apnoea patients: the French multicentre study Source: Eur Respir J 2009; 33: 1062-1067 Year: 2009 Relationship of oxidative stress and endothelial dysfunction in sleep apnoea Source: Eur Respir J 2011; 37: 873-879 Year: 2011 Acetazolamide reduces blood pressure and sleep disordered breathing in hypertensive obstructive sleep apnoea patients – a randomized controlled trial Source: International Congress 2017 – CPAP therapy Year: 2017 Day–night variations in endothelial dysfunction markers and haemostatic factors in sleep apnoea Source: Eur Respir J 2012; 39: 913-918 Year: 2012 Treatment effects of sleep apnoea: where are we now? Source: Eur Respir Rev 2007; 16: 146-168 Year: 2007 The effects of CPAP-withdrawal on cerebral vascular reactivity and brain oxygenation in patients with obstructive sleep apnoea: a randomised-controlled trial. Source: International Congress 2018 – Pathophysiological aspects of sleep-disordered breathing: intermittent hypoxia Year: 2018 Treatment of mild obstructive sleep apnea syndrome (OSAS) with excessive daytime sleepiness: a randomised controlled single blind trial of CPAP versus nasal strips Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Pathogenic role of angiotensin II and oxidised LDL in obstructive sleep apnoea Source: Eur Respir J 2009; 34: 1390-1398 Year: 2009 Nocturnal cerebral hypoxia in obstructive sleep apnoea: a randomised controlled trial Source: Eur Respir J, 51 (5) 1800032; 10.1183/13993003.00032-2018 Year: 2018 A prospective polysomnographic study on the evolution of complex sleep apnoea Source: Eur Respir J 2011; 38: 329-337 Year: 2011 A noninvasive device to measure endothelial dysfunction and its response to CPAP treatment in obstructive sleep apnoea patients Source: Annual Congress 2008 - Diagnostic aspects of sleep apnoea Year: 2008 Morphine alters respiratory control but not other key obstructive sleep apnoea phenotypes: a randomised trial Source: Eur Respir J, 55 (6) 1901344; 10.1183/13993003.01344-2019 Year: 2020 Effects of continuous nocturnal high oxygen concentrations in obstructive sleep apnea patients Source: Annual Congress 2005 - Control of breathing Year: 2005 Obstructive sleep apnoea severity and endothelial dysfunction: a meta-analysis of individual patient data. Source: International Congress 2019 – Challenging issues in the clinical aspects of sleep-disordered breathing Year: 2019 The 5-min pupillary alertness test is sensitive to modafinil: a placebo controlled study in patients with obstructive sleep apnea (OSA) Source: Annual Congress 2007 - Treatment options in obstructive sleep apnoea Year: 2007 Zonisamide reduces obstructive sleep apnoea: a randomised placebo-controlled study Source: Eur Respir J 2014; 44: 140-149 Year: 2014